Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06562127 · ClinicalTrials.gov registry record · NA

TBI Rehabilitation and Activation in Veterans

A NA study of Traumatic Brain Injury, sponsored by Northern California Institute of Research and Education.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
2
Study locations

NCT06562127: Recruiting NA study of Traumatic Brain Injury, sponsored by Northern California Institute of Research and Education.

NCT06562127 is a NA study of Traumatic Brain Injury that is actively recruiting participants, run by Northern California Institute of Research and Education. The registered enrollment target is 120 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06562127, a NA study of Traumatic Brain Injury, is actively recruiting participants, sponsored by Northern California Institute of Research and Education.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
2
Study locations

Study Summary

This trial will evaluate the impact of a multicomponent program (TBI Rehabilitation and Activation in Veterans; TRAIN-Vets) on improving cognitive function over an 8-month trial period in older Veterans with traumatic brain injury (TBI). Older Veterans with a history of TBI and subjective cognitive complaints will be enrolled and randomly assign to either the TRAIN-Vets intervention (consisting of aquatic-based exercise training, cognitive training, and lifestyle coaching) or the Health Education Control, where they will receive educational materials about brain health and healthy lifestyles.

Primary Outcome

Change in global composite score calculated from the z-scores from all cognitive measures \[Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV) Digit Span Forward, WAIS-IV Digit Span Backwards, WAIS-IV Digit Span Sequencing, Trail Making Test A and B; Delis-Kaplan Executive Function System (DKEFS) Stroop Inhibition Time \& Errors; DKEFS Stroop Inhibition-Switching Time \& Errors; DKEFS Verbal Fluency Switching; Benson Figure Copy and Recall; Hopkins Verbal Learning Test (HVLT) Learning and

Conditions Studied

Traumatic Brain Injury

Interventions

  • BEHAVIORAL TRAIN-Vets
  • BEHAVIORAL Health Education Control

Study Locations (2)

California

  • VA Palo Alto Health Care System - Palo Alto
  • San Francisco VA Health Care System - San Francisco

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-05-12
Est. Completion 2028-02
Phase NA
Northern California Institute of Research and Education

6 total trials

What NCT06562127 shows while recruiting

NCT06562127 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (57% lower).

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which TRAIN-Vets is the first listed.

NCT06562127 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06562127 about?

NCT06562127 is a clinical study titled "TBI Rehabilitation and Activation in Veterans". This trial will evaluate the impact of a multicomponent program (TBI Rehabilitation and Activation in Veterans; TRAIN-Vets) on improving cognitive function over an 8-month trial period in older Veterans with traumatic brain injury (TBI). Older Veterans with a history of TBI and subjective cognitive ...

What is the current status of trial NCT06562127?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-05-12. Estimated completion is 2028-02.

What conditions does trial NCT06562127 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT06562127?

The interventions under investigation include: TRAIN-Vets (BEHAVIORAL), Health Education Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT06562127?

This trial is sponsored by Northern California Institute of Research and Education, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06562127 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06562127's enrollment target sits among peer trials

120 56th of 171 higher than 113 of 171 other Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06562127

Source: ClinicalTrials.gov NCT06562127, the US trial registry maintained by the National Library of Medicine. NCT06562127 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.